235 related articles for article (PubMed ID: 25325283)
1. Human health effects of dichloromethane: key findings and scientific issues.
Schlosser PM; Bale AS; Gibbons CF; Wilkins A; Cooper GS
Environ Health Perspect; 2015 Feb; 123(2):114-9. PubMed ID: 25325283
[TBL] [Abstract][Full Text] [Related]
2. Approaches to cancer assessment in EPA's Integrated Risk Information System.
Gehlhaus MW; Gift JS; Hogan KA; Kopylev L; Schlosser PM; Kadry AR
Toxicol Appl Pharmacol; 2011 Jul; 254(2):170-80. PubMed ID: 21034767
[TBL] [Abstract][Full Text] [Related]
3. Human health effects of tetrachloroethylene: key findings and scientific issues.
Guyton KZ; Hogan KA; Scott CS; Cooper GS; Bale AS; Kopylev L; Barone S; Makris SL; Glenn B; Subramaniam RP; Gwinn MR; Dzubow RC; Chiu WA
Environ Health Perspect; 2014 Apr; 122(4):325-34. PubMed ID: 24531164
[TBL] [Abstract][Full Text] [Related]
4. Workshop overview: reassessment of the cancer risk of dichloromethane in humans.
Starr TB; Matanoski G; Anders MW; Andersen ME
Toxicol Sci; 2006 May; 91(1):20-8. PubMed ID: 16507920
[TBL] [Abstract][Full Text] [Related]
5. DNA-protein cross-links (DPX) and cell proliferation in B6C3F1 mice but not Syrian golden hamsters exposed to dichloromethane: pharmacokinetics and risk assessment with DPX as dosimeter.
Casanova M; Conolly RB; Heck H d'A
Fundam Appl Toxicol; 1996 May; 31(1):103-16. PubMed ID: 8998946
[TBL] [Abstract][Full Text] [Related]
6. Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations.
David RM; Clewell HJ; Gentry PR; Covington TR; Morgott DA; Marino DJ
Regul Toxicol Pharmacol; 2006 Jun; 45(1):55-65. PubMed ID: 16439044
[TBL] [Abstract][Full Text] [Related]
7. Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.
Marino DJ; Clewell HJ; Gentry PR; Covington TR; Hack CE; David RM; Morgott DA
Regul Toxicol Pharmacol; 2006 Jun; 45(1):44-54. PubMed ID: 16442684
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of two different metabolic hypotheses for dichloromethane toxicity using physiologically based pharmacokinetic modeling for in vivo inhalation gas uptake data exposure in female B6C3F1 mice.
Evans MV; Caldwell JC
Toxicol Appl Pharmacol; 2010 May; 244(3):280-90. PubMed ID: 20153349
[TBL] [Abstract][Full Text] [Related]
9. Methylene chloride induced mouse liver and lung tumours: an overview of the role of mechanistic studies in human safety assessment.
Green T
Hum Exp Toxicol; 1997 Jan; 16(1):3-13. PubMed ID: 9023569
[TBL] [Abstract][Full Text] [Related]
10. US EPA's IRIS pilot program: establishing IRIS as a centralized, peer-reviewed data base with agency consensus. Integrated Risk Information System.
Mills A; Foureman GL
Toxicology; 1998 May; 127(1-3):85-95. PubMed ID: 9699796
[TBL] [Abstract][Full Text] [Related]
11. Physiologically based pharmacokinetics and cancer risk assessment.
Andersen ME; Krishnan K
Environ Health Perspect; 1994 Jan; 102 Suppl 1(Suppl 1):103-8. PubMed ID: 8187697
[TBL] [Abstract][Full Text] [Related]
12. Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene.
Clewell HJ; Andersen ME
Crit Rev Toxicol; 2004; 34(5):385-445. PubMed ID: 15560567
[TBL] [Abstract][Full Text] [Related]
13. Effects of glutathione transferase theta polymorphism on the risk estimates of dichloromethane to humans.
El-Masri HA; Bell DA; Portier CJ
Toxicol Appl Pharmacol; 1999 Aug; 158(3):221-30. PubMed ID: 10438655
[TBL] [Abstract][Full Text] [Related]
14. Translational research to develop a human PBPK models tool kit-volatile organic compounds (VOCs).
Mumtaz MM; Ray M; Crowell SR; Keys D; Fisher J; Ruiz P
J Toxicol Environ Health A; 2012; 75(1):6-24. PubMed ID: 22047160
[TBL] [Abstract][Full Text] [Related]
15. Inhalation cancer risk assessment for environmental exposure to hexavalent chromium: Comparison of margin-of-exposure and linear extrapolation approaches.
Proctor DM; Bhat V; Suh M; Reichert H; Jiang X; Thompson CM
Regul Toxicol Pharmacol; 2021 Aug; 124():104969. PubMed ID: 34089813
[TBL] [Abstract][Full Text] [Related]
16. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
17. Carcinogenicity of ethylene oxide: key findings and scientific issues.
Jinot J; Fritz JM; Vulimiri SV; Keshava N
Toxicol Mech Methods; 2018 Jun; 28(5):386-396. PubMed ID: 29210319
[TBL] [Abstract][Full Text] [Related]
18. Insights from epidemiology into dichloromethane and cancer risk.
Cooper GS; Scott CS; Bale AS
Int J Environ Res Public Health; 2011 Aug; 8(8):3380-98. PubMed ID: 21909313
[TBL] [Abstract][Full Text] [Related]
19. Dichloromethane (methylene chloride): metabolism to formaldehyde and formation of DNA-protein cross-links in B6C3F1 mice and Syrian golden hamsters.
Casanova M; Deyo DF; Heck H
Toxicol Appl Pharmacol; 1992 May; 114(1):162-5. PubMed ID: 1585369
[TBL] [Abstract][Full Text] [Related]
20. Use of genetic toxicology data in U.S. EPA risk assessment: the mercury study report as an example.
Schoeny R
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):663-73. PubMed ID: 8781402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
